AR044868A1 - Complemento de aminoacido para un ecosistema de microbiota saludable - Google Patents

Complemento de aminoacido para un ecosistema de microbiota saludable

Info

Publication number
AR044868A1
AR044868A1 ARP040102181A ARP040102181A AR044868A1 AR 044868 A1 AR044868 A1 AR 044868A1 AR P040102181 A ARP040102181 A AR P040102181A AR P040102181 A ARP040102181 A AR P040102181A AR 044868 A1 AR044868 A1 AR 044868A1
Authority
AR
Argentina
Prior art keywords
healthy
ecosystem
microbiote
amino acid
rebuild
Prior art date
Application number
ARP040102181A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33522257&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR044868(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of AR044868A1 publication Critical patent/AR044868A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Una composición nutritiva para reconstruir un ecosistema de microbiota saludable y óptimo en humanos o animales. En particular, se refiere a un vehículo ingerible que contiene aminoácidos específicos diseñado para favorecer el crecimiento de bacterias favorables para la salud de los individuos o para reducir el riesgo de desarrollar fenómenos nocivos. También se relaciona con el uso de aminoácidos específicos para reconstruir un ecosistema de microbiota saludable y óptimo en humanos o animales, en particular en infantes, pacientes críticamente enfermos, en el caso de enfermedades crónicas o de cualquier tipo de estrés que impacte el intestino y en adultos mayores.
ARP040102181A 2003-06-23 2004-06-22 Complemento de aminoacido para un ecosistema de microbiota saludable AR044868A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03014037 2003-06-23

Publications (1)

Publication Number Publication Date
AR044868A1 true AR044868A1 (es) 2005-10-05

Family

ID=33522257

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102181A AR044868A1 (es) 2003-06-23 2004-06-22 Complemento de aminoacido para un ecosistema de microbiota saludable

Country Status (9)

Country Link
US (5) US20070036836A1 (es)
EP (2) EP1638418B1 (es)
AR (1) AR044868A1 (es)
CA (1) CA2532473C (es)
DK (1) DK1638418T3 (es)
ES (1) ES2391558T3 (es)
PT (1) PT1638418E (es)
TW (1) TW200513197A (es)
WO (1) WO2004112512A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638418B1 (en) * 2003-06-23 2012-08-29 Nestec S.A. Amino acid supplementation for a healthy microbiota ecosystem
FI20051319L (fi) * 2005-12-22 2007-06-23 Cyflo Oy Menetelmä eläimen ja/tai ihmisen ravitsemuksen ja hyvinvoinnin ja eläinten tuottavuuden seuraamiseksi ja kehittämiseksi
EP2165713B1 (en) 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
JP5877902B2 (ja) 2011-08-17 2016-03-08 マイクロバイオーム セラピューティクス，エルエルシー バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
WO2015154257A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and, nutritional systems comprising them
WO2015154259A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US20180281892A1 (en) * 2017-03-31 2018-10-04 Shun Xin Co., Ltd. Anti-disengagement fine-adjustable quick-detachable structure
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
EP3646739A1 (en) 2018-11-01 2020-05-06 N.V. Nutricia Nutritional composition comprising urea and non-digestible oligosaccharides

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1159615A (en) 1966-05-16 1969-07-30 Vivonex Corp A Nutritionally Adequate, Non-Residual Dietary Composition for the reduction of the Intestinal Microflora Level
US4491589A (en) * 1982-05-17 1985-01-01 The Trustees Of Columbia University In The City Of New York Amino acid solutions for parenteral nutrition and methods of formulation and use
JPS59115574A (ja) 1982-12-23 1984-07-04 Semiconductor Energy Lab Co Ltd 光電変換装置作製方法
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5310768A (en) * 1987-10-29 1994-05-10 Ab Erik Vinnars Method for improving the glutamine content in skeletal muscle and composition therefore
JPH0779684B2 (ja) * 1989-02-27 1995-08-30 森永乳業株式会社 ビフィズス菌増殖促進組成物
US5411757A (en) * 1989-11-09 1995-05-02 Buist; Neil R. M. Palatable balanced amino acid-modified diet
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
US5817760A (en) * 1992-03-13 1998-10-06 Merck & Co., Inc. Human A3 adenosine receptors
AU682894B2 (en) * 1993-10-28 1997-10-23 Institut National De La Recherche Agronomique Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
CN1181244A (zh) * 1996-10-28 1998-05-13 内蒙古呼和浩特市孔源生物保健总厂 一种保健口服液
ES2265669T3 (es) * 1997-09-16 2007-02-16 Societe Des Produits Nestle S.A. Uso de una composicion nutritiva especifica para un organo.
JP2001516570A (ja) * 1997-09-16 2001-10-02 ヴォルフ ゲオルグ フォースマン ビフィドゲニックペプチド類
WO1999064022A1 (en) * 1998-06-10 1999-12-16 Crum Albert B Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
US6322826B2 (en) * 1998-06-16 2001-11-27 Mathias Christian Zohoungbogbo Dietetic food composition and dietetic method using such composition
AU6474099A (en) * 1998-10-20 2000-05-08 Societe Des Produits Nestle S.A. Protein for treatment or prevention of a gi tract disorder
US6183099B1 (en) 1999-06-09 2001-02-06 Timex Corporation Light guide for illuminating a dial
US6833350B2 (en) * 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
DE60118888T3 (de) 2000-02-04 2010-09-23 Société des Produits Nestlé S.A. Verfahren zur erhöhung bzw. verbesserung der synthese von mucin
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
CN1229115C (zh) 2000-02-17 2005-11-30 惠氏公司 含有益生素物质的营养配方
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
RU2268069C2 (ru) 2000-04-18 2006-01-20 Сосьете Де Продюи Нестле С.А. Питательные модули
DE10024746A1 (de) * 2000-05-19 2001-11-22 Ih Brt N V Futtermittelzusatz
US6592863B2 (en) 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
EP1228707A1 (en) 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
EP1281325A1 (en) * 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Nutritional composition preventing bacterial overgrowth
EP1638418B1 (en) * 2003-06-23 2012-08-29 Nestec S.A. Amino acid supplementation for a healthy microbiota ecosystem
ES2677868T3 (es) * 2003-10-16 2018-08-07 Nestec S.A. Composición nutricional frente a los efectos secundarios de la quimioterapia o de la radioterapia

Also Published As

Publication number Publication date
US20080274127A1 (en) 2008-11-06
CA2532473C (en) 2013-08-06
DK1638418T3 (da) 2012-09-17
EP1638418A1 (en) 2006-03-29
US20070036836A1 (en) 2007-02-15
PT1638418E (pt) 2012-09-20
US20160128960A1 (en) 2016-05-12
ES2391558T3 (es) 2012-11-27
TW200513197A (en) 2005-04-16
US20180153842A1 (en) 2018-06-07
EP1638418B1 (en) 2012-08-29
US20140335130A1 (en) 2014-11-13
EP2382874A1 (en) 2011-11-02
US9271958B2 (en) 2016-03-01
WO2004112512A1 (en) 2004-12-29
US9884033B2 (en) 2018-02-06
CA2532473A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
AR044868A1 (es) Complemento de aminoacido para un ecosistema de microbiota saludable
CR8380A (es) Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos
AR044888A1 (es) Formula nutritiva para la funcion optima de la barrera del intestino
GT200500378A (es) Macrolidos
AR058327A1 (es) Vacuna terapeutica
CL2004001550A1 (es) Formula para infantes o para etapa siguiente del crecimiento, que comprende proteinas, lipidos, carbohidratos y un probiotico, en donde la fuente de lipidos incluye al menos un lc-pufa, y sus usos.
BR112012015753A2 (pt) composição nutricional com alto teor de proteína e baixa caloria para o estímulo de síntese de proteína muscular
GB2514736A (en) Oral care system method and kit
UY31497A1 (es) Nuevos compuestos para el tratamiento de trastornos del snc
UY28757A1 (es) Compuestos de pirazolina substituidos, su preparación y su uso como medicamentos
EA200970224A1 (ru) Лечение заболеваний хряща
CL2019000132A1 (es) Composición lipídica para usar en infantes y niños pequeños para promover el confort del intestino y la óptima absorción de grasa y calcio.
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
UY31609A1 (es) "(-) ácido 2-[1-(7-metil-2-(morfolin-4-il) 4-oxo-4h-pirido[1,2-a]pirimidin-9-il)etilamino]benzoico enantioméricamente puro, su uso en terapia médica, y una composición farmacéutica que lo comprende-026."
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
UA110463C2 (ru) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 4-{[9-ХЛОР-7-(2-ФТОР-6-МЕТОКСИФЕНІЛ)-5Н-ПІРИМІДО[5,4-d][2]БЕНЗАЗЕПІН-2-ІЛ]АМІНО}-2-МЕТОКСИБЕНЗОЙНОЇ КИСЛОТИ ДЛЯ ЛІКУВАННЯ РАКУ Й ІНШИХ ЗАХВОРЮВАНЬ І ПОРУШЕНЬ СТАНУ ЗДОРОВ'Я
UY28311A1 (es) Suplemento dietetico y metodo para el tratamiento y prevención de úlceras en el tracto digestivo en equinos y otros animales.
NO20055390D0 (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
BRPI0816993A2 (pt) Uso de uma composição, e, composição nutricional
BRPI0712561B8 (pt) Uso de 3-oxo-3,4-diidro-2-pirazinacarboxamida
DE602004010691D1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
AR076576A1 (es) Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos
ME00489B (me) NOVA SINERGIČKA KOMBINACIJA KOJA UKLJUČUJE ROFLUMILAST l FERMOTEROL
ITBO20030261A1 (it) Unita'di irraggiamento luminoso per diagnosi e cura di problemi cutanei.
BRPI0520593A2 (pt) uso de betaìna, dimetilglicina ou sais internos de betaìna nas formas anidra e hidratada, e, composição nutricional

Legal Events

Date Code Title Description
FB Suspension of granting procedure